VEGF-mediated suppression of cell proliferation and invasion by miR-410 in osteosarcoma

Dong Zhao1, Peng Jia, Wenliang Wang

  • 1Department of Orthopedics, Affiliated Hospital, Logistics University of Chinese People's Armed Police Forces, No. 220 Chenglin Road, Hedong district, Tianjin, 300162, China, zhaodongtj@163.com.

Insights

MicroRNA-410 (miR-410) is downregulated in osteosarcoma (OS) and inhibits tumor growth by targeting VEGF. Restoring miR-410 shows therapeutic potential for OS treatment.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • MicroRNAs (miRNAs) are key regulators of gene expression implicated in cancer.
  • Aberrant miRNA expression is a hallmark of various cancers, including osteosarcoma (OS).
  • Understanding specific miRNA roles in OS is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of miR-410 in osteosarcoma (OS) diagnosis and therapy.
  • To determine the relationship between miR-410 and Vascular Endothelial Growth Factor (VEGF) in OS.
  • To evaluate the therapeutic potential of miR-410 in OS.

Main Methods:

  • Western blot analysis to assess protein expression (VEGF).
  • Luciferase reporter assay to confirm direct targeting of VEGF by miR-410.
  • In vitro assays (MTT, Transwell, flow cytometry) to evaluate effects on OS cells.
  • In vivo studies to assess tumor growth inhibition.

Main Results:

  • miR-410 was lowly expressed and inversely correlated with VEGF in OS specimens.
  • miR-410 directly targeted and repressed VEGF expression.
  • Overexpression of miR-410 inhibited OS cell proliferation, induced apoptosis, and suppressed tumor growth in vivo.
  • Restoration of VEGF reversed the anti-tumor effects of miR-410.

Conclusions:

  • miR-410 acts as a tumor suppressor in osteosarcoma by targeting VEGF.
  • The miR-410/VEGF axis plays a significant role in OS cell regulation.
  • miR-410 holds promise as a diagnostic marker and therapeutic target for osteosarcoma.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
11.1K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.4K